230 related articles for article (PubMed ID: 26195821)
1. Orphan Nuclear Receptor Nur77 Inhibits Cardiac Hypertrophic Response to Beta-Adrenergic Stimulation.
Yan G; Zhu N; Huang S; Yi B; Shang X; Chen M; Wang N; Zhang GX; Talarico JA; Tilley DG; Gao E; Sun J
Mol Cell Biol; 2015 Oct; 35(19):3312-23. PubMed ID: 26195821
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional up-regulation of relaxin-3 by Nur77 attenuates β-adrenergic agonist-induced apoptosis in cardiomyocytes.
You X; Guo ZF; Cheng F; Yi B; Yang F; Liu X; Zhu N; Zhao X; Yan G; Ma XL; Sun J
J Biol Chem; 2018 Sep; 293(36):14001-14011. PubMed ID: 30006349
[TBL] [Abstract][Full Text] [Related]
3. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
[TBL] [Abstract][Full Text] [Related]
4. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
5. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
Dai H; Jia G; Liu X; Liu Z; Wang H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
[TBL] [Abstract][Full Text] [Related]
7. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
Le K; Li R; Xu S; Wu X; Huang H; Bao Y; Cai Y; Lan T; Moss J; Li C; Zou J; Shen X; Liu P
Arch Biochem Biophys; 2012 Feb; 518(1):71-8. PubMed ID: 22198280
[TBL] [Abstract][Full Text] [Related]
8. Orphan nuclear receptor Nur77 is a novel negative regulator of endothelin-1 expression in vascular endothelial cells.
Qin Q; Chen M; Yi B; You X; Yang P; Sun J
J Mol Cell Cardiol; 2014 Dec; 77():20-8. PubMed ID: 25284689
[TBL] [Abstract][Full Text] [Related]
9. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
Takaya T; Kawamura T; Morimoto T; Ono K; Kita T; Shimatsu A; Hasegawa K
J Biol Chem; 2008 Apr; 283(15):9828-35. PubMed ID: 18252717
[TBL] [Abstract][Full Text] [Related]
10. Transactivated EGFR mediates α₁-AR-induced STAT3 activation and cardiac hypertrophy.
Li Y; Zhang H; Liao W; Song Y; Ma X; Chen C; Lu Z; Li Z; Zhang Y
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1941-51. PubMed ID: 21856923
[TBL] [Abstract][Full Text] [Related]
11. NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression.
Wang T; Zhai M; Xu S; Ponnusamy M; Huang Y; Liu CY; Wang M; Shan C; Shan PP; Gao XQ; Wang K; Chen XZ; Liu J; Xie JY; Zhang DY; Zhou LY; Wang K
Theranostics; 2020; 10(2):553-566. PubMed ID: 31903137
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
[TBL] [Abstract][Full Text] [Related]
13. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
Sugiyama A; Okada M; Yamawaki H
Eur J Pharmacol; 2020 Mar; 871():172849. PubMed ID: 31843516
[TBL] [Abstract][Full Text] [Related]
14. Orphan nuclear receptor Nur77 affects cardiomyocyte calcium homeostasis and adverse cardiac remodelling.
Medzikovic L; Schumacher CA; Verkerk AO; van Deel ED; Wolswinkel R; van der Made I; Bleeker N; Cakici D; van den Hoogenhof MM; Meggouh F; Creemers EE; Remme CA; Baartscheer A; de Winter RJ; de Vries CJ; Arkenbout EK; de Waard V
Sci Rep; 2015 Oct; 5():15404. PubMed ID: 26486271
[TBL] [Abstract][Full Text] [Related]
15. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
Nunn C; Zou MX; Sobiesiak AJ; Roy AA; Kirshenbaum LA; Chidiac P
Cell Signal; 2010 Aug; 22(8):1231-9. PubMed ID: 20362664
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin-GATA4 pathway is involved in beta-adrenergic agonist-responsive endothelin-1 transcription in cardiac myocytes.
Morimoto T; Hasegawa K; Wada H; Kakita T; Kaburagi S; Yanazume T; Sasayama S
J Biol Chem; 2001 Sep; 276(37):34983-9. PubMed ID: 11435416
[TBL] [Abstract][Full Text] [Related]
17. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
[TBL] [Abstract][Full Text] [Related]
18. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
[TBL] [Abstract][Full Text] [Related]
20. β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.
Murray DR; Mummidi S; Valente AJ; Yoshida T; Somanna NK; Delafontaine P; Dinarello CA; Chandrasekar B
J Mol Cell Cardiol; 2012 Jan; 52(1):206-18. PubMed ID: 22004899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
